tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market

Maze Therapeutics, Inc. (MAZE) Stock News & Sentiment

Compare
17 Followers
Positive Outlook for Maze Therapeutics: Buy Rating Reiterated Amid Promising Drug Developments and Strong Financial Position
Premium
Ratings
Positive Outlook for Maze Therapeutics: Buy Rating Reiterated Amid Promising Drug Developments and Strong Financial Position
30d ago
Positive Outlook for Maze Therapeutics: Promising Pipeline and Strong Financial Position Justify Buy Rating
Premium
Ratings
Positive Outlook for Maze Therapeutics: Promising Pipeline and Strong Financial Position Justify Buy Rating
3M ago
Promising Drug Candidates and Market Potential Drive Buy Rating for Maze Therapeutics
Premium
Ratings
Promising Drug Candidates and Market Potential Drive Buy Rating for Maze Therapeutics
4M ago

News Score - Last 7 Days

Neutral
MAZE
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MAZE’s Media Buzz Sentiment?
Currently, no data Available
What is MAZE’s weekly average amount of articles?
Currently, no data Available
What is MAZE’s News Sentiment?
50% of articles about MAZE were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    OGNOrganon
    VERVVerve Therapeutics
    PDEXPro-Dex
    USNAUSANA Health
    AVDLAvadel Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis